PMID: 1194676Oct 1, 1975Paper

Quantitative estimation of cytotoxic activity of immune lymphocytes using 51Cr-labelled peritoneal macrophages as target cells

Journal of Immunological Methods
G I DrizlikhB D Brondz

Abstract

Peritoneal macrophages labelled with 51Cr in suspension and cultivated for 48 hr on glass pretreated with poly-L-lysine were used as target cells for determination of the cytotoxic effect of immune lymphocytes. 51Cr release from such target cell from different strains of mice is 15.5 +/- 0.8% of the total target cell radioactivity after 20 hr incubation with normal allogeneic lymphocytes. The use of 2% sodium dodecylsulphate ensures 100 percent solubilisation of labelled target cells growing on the glass surface and permits the cytotoxic effect to be determined by both 51Cr release and measuring the label retained by the intact cells. The two methods proved to be accurate, reproducible and in accord with each other as well as with the method of direct cell counting. Determination of released 51Cr enables the cytotoxic effect of lymphocytes to be measured after 4 hr incubation with the macrophage monolayer. SaI and Mc11 ascitic sarcomas display different sensitivities to the cytotoxic effect of immune lymphocytes and require different optimum conditions for its development.

References

Jan 1, 1972·Transplantation Reviews·P HäyryM Virolainen
Aug 1, 1973·Transplantation·T B StromJ P Merrill
Apr 1, 1973·The Journal of Experimental Medicine·R D Stulting, G Berke
Dec 1, 1973·Cellular Immunology·R D Stulting, G Berke
Dec 1, 1971·The Journal of Experimental Medicine·P GolsteinH Wigzell
May 27, 1971·The New England Journal of Medicine·B R Bloom

❮ Previous
Next ❯

Citations

Jan 1, 1978·Biulleten' eksperimental'noĭ biologii i meditsiny·A P Suslov, U Miuller
Jun 1, 1978·Biulleten' eksperimental'noĭ biologii i meditsiny·A P SuslovS G Egorova
Jan 1, 1979·Scandinavian Journal of Immunology·B D BrondzG I Drizlikh
Feb 1, 1977·European Journal of Immunology·C CarnaudJ F Bach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.